Handelsbanken Fonder’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167K | Buy |
96,900
+24,200
| +33% | +$41.7K | ﹤0.01% | 1502 |
|
|
2025
Q1 | $242K | Hold |
72,700
| – | – | ﹤0.01% | 1461 |
|
|
2024
Q4 | $538K | Sell |
72,700
-2,100
| -3% | -$15.5K | ﹤0.01% | 1253 |
|
|
2024
Q3 | $702K | Buy |
74,800
+11,500
| +18% | +$108K | ﹤0.01% | 1092 |
|
|
2024
Q2 | $508K | Sell |
63,300
-155,600
| -71% | -$1.25M | ﹤0.01% | 1149 |
|
|
2024
Q1 | $3.24M | Buy |
218,900
+163,200
| +293% | +$2.42M | 0.01% | 504 |
|
|
2023
Q4 | $453K | Buy |
55,700
+26,500
| +91% | +$216K | ﹤0.01% | 1199 |
|
|
2023
Q3 | $133K | Hold |
29,200
| – | – | ﹤0.01% | 1525 |
|
|
2023
Q2 | $206K | Buy |
29,200
+4,300
| +17% | +$30.3K | ﹤0.01% | 1488 |
|
|
2023
Q1 | $152K | Hold |
24,900
| – | – | ﹤0.01% | 1495 |
|
|
2022
Q4 | $159K | Hold |
24,900
| – | – | ﹤0.01% | 1468 |
|
|
2022
Q3 | $239K | Hold |
24,900
| – | – | ﹤0.01% | 1365 |
|
|
2022
Q2 | $275K | Hold |
24,900
| – | – | ﹤0.01% | 1370 |
|
|
2022
Q1 | $415K | Hold |
24,900
| – | – | ﹤0.01% | 1325 |
|
|
2021
Q4 | $475K | Hold |
24,900
| – | – | ﹤0.01% | 1384 |
|
|
2021
Q3 | $614K | Hold |
24,900
| – | – | ﹤0.01% | 1214 |
|
|
2021
Q2 | $648K | Hold |
24,900
| – | – | ﹤0.01% | 1190 |
|
|
2021
Q1 | $788K | Hold |
24,900
| – | – | ﹤0.01% | 958 |
|
|
2020
Q4 | $1.16M | Buy |
24,900
+4,400
| +21% | +$204K | 0.01% | 761 |
|
|
2020
Q3 | $675K | Hold |
20,500
| – | – | ﹤0.01% | 854 |
|
|
2020
Q2 | $563K | Buy |
+20,500
| New | +$563K | ﹤0.01% | 913 |
|